A new pretargeted radioimmunotherapy (PRIT) technique has been shown to be safe and effective in eradicating tumors from a ...
The Virtus KAR Small-Cap Growth Fund returned -9.88% (Class I) in the quarter, underperforming the Russell 2000® Growth Index ...
Option Care Health (OPCH) stock hits a 5-year low as the company cuts its growth outlook after missing Street forecasts with ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
There is a long tradition of people giving draft picks a grade less than 24 hours after they’ve been made. Some of them are ...
Off-the-shelf cema-cel clears MRD at more than triple the rate of observation alone—and may propel a shift to frontline use ...
eYe Junya Watanabe MAN reinterprets the Alpha Industries MA-1 as a reversible denim-trucker hybrid. The Japanese-made design blends olive flight nylon with washed denim, featuring deconstructed orange ...
FDA clears InVera infusion device to treat chronic venous disease, including varicose veins. The device is now cleared for use in the United States and European Union. Lowell Kabnick, MD, will present ...
Abstract: Type 1 diabetes treatment still poses difficulties because it has complex and time-varying glucose-insulin dynamics. The proposed study aims to provide a closed-loop insulin infusion system ...
Abstract: In order to monitor the infusion situation of patients in real time, assist medical staff to replace the liquid medicine in time, solve the hidden dangers caused by the shortage of medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results